Real-time enrollment status for this vexas syndrome clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 9:03 PM UTC
| NCT Number | NCT06782373 |
| Recruiting Status | Recruiting |
| Condition | VEXAS Syndrome |
| Phase | PHASE2 |
| Target Enrollment | 156 participants |
| Active Locations | 9 sites in the US |
| Sponsor | Swedish Orphan Biovitrum |
| Last Updated on CT.gov | October 16, 2026 (21 hours ago) |
As of October 16, 2026: Clinical trial NCT06782373 is currently recruiting participants. This phase2 study for vexas syndrome is actively seeking new participants at 9 locations across the United States. The study is sponsored by Swedish Orphan Biovitrum. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06782373 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 9 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06782373 was last updated 21 hours ago (October 16, 2026). HelloStudys verifies this status automatically.